{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:23:24Z","timestamp":1789212204094,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Niemann\u2013Pick disease, type C1 (NPC1) is a neurodegenerative, lysosomal storage disorder due to mutation of the<jats:italic>NPC1<\/jats:italic>gene. The NPC1 phenotype is characterized by progressive neuronal dysfunction, including cerebellar ataxia and dementia. There is histological evidence of neuroinflammation and progressive neuronal loss, with cerebellar Purkinje cells particularly vulnerable to loss of NPC1 function. Necroptosis was evaluated as a mechanism of neuronal loss. Receptor-interacting protein kinase 1 (RIP1) and RIP3 are key components of the necrosomal complex that regulates necroptotic cell death. We report increased expression of RIP1 and RIP3 in NPC1 fibroblasts, NPC1 iPS cell-derived neuronal precursors, and in cerebellar tissue from both NPC1 mice and patients. Our data suggest a positive correlation between NPC1 neurological disease severity and assembly of the necrosome complex. Furthermore, we demonstrate that pharmacological inhibition of RIP1 decreases cell death both<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>. Treatment of<jats:italic>Npc1<\/jats:italic>-mutant mice with necrostatin-1, an allosteric inhibitor of RIP1, significantly delayed cerebellar Purkinje cell loss, progression of neurological symptoms, and death. Collectively, our data identified necroptosis as a key component of the molecular network that contributes to neuronal loss in NPC1 and establish that inhibition of necroptosis is a potential therapeutic intervention.<\/jats:p>","DOI":"10.1038\/cddis.2016.16","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T13:47:02Z","timestamp":1458222422000},"page":"e2147-e2147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Necroptosis in Niemann\u2013Pick disease, type C1: a potential therapeutic target"],"prefix":"10.1038","volume":"7","author":[{"given":"A","family":"Cougnoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cluzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Burkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Wassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F D","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,17]]},"reference":[{"key":"BFcddis201616_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT . Niemann-Pick disease type C. Orphanet J Rare Dis 2010; 5: 16.","journal-title":"Orphanet J Rare Dis"},{"key":"BFcddis201616_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/gim.2015.25","volume":"18","author":"CA Wassif","year":"2015","unstructured":"Wassif CA, Cross JL, Iben J, Sanchez-Pulido L, Cougnoux A, Platt FM et al. High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med 2015; 18: 41\u201348.","journal-title":"Genet Med"},{"key":"BFcddis201616_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbalip.2004.08.011","volume":"1685","author":"SU Walkley","year":"2004","unstructured":"Walkley SU, Suzuki K . Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim Biophys Acta 2004; 1685: 48\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis201616_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nm.1876","volume":"14","author":"E Lloyd-Evans","year":"2008","unstructured":"Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 2008; 14: 1247\u20131255.","journal-title":"Nat Med"},{"key":"BFcddis201616_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE . Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 2007; 6: 765\u2013772.","journal-title":"Lancet Neurol"},{"key":"BFcddis201616_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","volume":"99","author":"JE Wraith","year":"2010","unstructured":"Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab 2010; 99: 351\u2013357.","journal-title":"Mol Genet Metab"},{"key":"BFcddis201616_CR7","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.celrep.2013.10.042","volume":"5","author":"S Sarkar","year":"2013","unstructured":"Sarkar S, Carroll B, Buganim Y, Maetzel D, Ng AH, Cassady JP et al. Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease. Cell Rep 2013; 5: 1302\u20131315.","journal-title":"Cell Rep"},{"key":"BFcddis201616_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.stemcr.2014.03.014","volume":"2","author":"D Maetzel","year":"2014","unstructured":"Maetzel D, Sarkar S, Wang H, Abi-Mosleh L, Xu P, Cheng AW et al. Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Rep 2014; 2: 866\u2013880.","journal-title":"Stem Cell Rep"},{"key":"BFcddis201616_CR9","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1093\/hmg\/dds324","volume":"21","author":"MJ Elrick","year":"2012","unstructured":"Elrick MJ, Yu T, Chung C, Lieberman AP . Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease. Hum Mol Genet 2012; 21: 4876\u20134887.","journal-title":"Hum Mol Genet"},{"key":"BFcddis201616_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ymgme.2004.08.017","volume":"84","author":"YP Wu","year":"2005","unstructured":"Wu YP, Mizukami H, Matsuda J, Saito Y, Proia RL, Suzuki K . Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol Genet Metab 2005; 84: 9\u201317.","journal-title":"Mol Genet Metab"},{"key":"BFcddis201616_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/jnr.10257","volume":"68","author":"RP Erickson","year":"2002","unstructured":"Erickson RP, Bernard O . Studies on neuronal death in the mouse model of Niemann-Pick C disease. J Neurosci Res 2002; 68: 738\u2013744.","journal-title":"J Neurosci Res"},{"key":"BFcddis201616_CR12","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1111\/j.0953-816X.2004.03439.x","volume":"19","author":"CL Hunter","year":"2004","unstructured":"Hunter CL, Quintero EM, Gilstrap L, Bhat NR, Granholm AC . Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur J Neurosci 2004; 19: 3305\u20133316.","journal-title":"Eur J Neurosci"},{"key":"BFcddis201616_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107\u2013120.","journal-title":"Cell Death Differ"},{"key":"BFcddis201616_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-386039-2.00001-8","volume":"289","author":"L Galluzzi","year":"2011","unstructured":"Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P et al. Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol 2011; 289: 1\u201335.","journal-title":"Int Rev Cell Mol Biol"},{"key":"BFcddis201616_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1124\/mol.107.043844","volume":"73","author":"AB Weinglass","year":"2008","unstructured":"Weinglass AB, Kohler MG, Nketiah EO, Liu J, Schmalhofer W, Thomas A et al. Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake. Mol Pharmacol 2008; 73: 1072\u20131084.","journal-title":"Mol Pharmacol"},{"key":"BFcddis201616_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2003.11.001","volume":"124","author":"EM Quintero","year":"2004","unstructured":"Quintero EM, Willis LM, Zaman V, Lee J, Boger HA, Tomac A et al. Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience 2004; 124: 137\u2013146.","journal-title":"Neuroscience"},{"key":"BFcddis201616_CR17","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1073\/pnas.96.4.1657","volume":"96","author":"SC Patel","year":"1999","unstructured":"Patel SC, Suresh S, Kumar U, Hu CY, Cooney A, Blanchette-Mackie EJ et al. Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. Proc Natl Acad Sci USA 1999; 96: 1657\u20131662.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis201616_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cne.1149","volume":"433","author":"DC German","year":"2001","unstructured":"German DC, Quintero EM, Liang CL, Ng B, Punia S, Xie C et al. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J Comp Neurol 2001; 433: 415\u2013425.","journal-title":"J Comp Neurol"},{"key":"BFcddis201616_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1039\/C3MT00308F","volume":"6","author":"YH Hung","year":"2014","unstructured":"Hung YH, Faux NG, Killilea DW, Yanjanin N, Firnkes S, Volitakis I et al. Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics 2014; 6: 542\u2013553.","journal-title":"Metallomics"},{"key":"BFcddis201616_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313\u2013321.","journal-title":"Nat Chem Biol"},{"key":"BFcddis201616_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","volume":"22","author":"DE Christofferson","year":"2010","unstructured":"Christofferson DE, Yuan J . Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 2010; 22: 263\u2013268.","journal-title":"Curr Opin Cell Biol"},{"key":"BFcddis201616_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nm.3449","volume":"20","author":"EB Vitner","year":"2014","unstructured":"Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD et al. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat Med 2014; 20: 204\u2013208.","journal-title":"Nat Med"},{"key":"BFcddis201616_CR23","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1038\/cddis.2010.94","volume":"2","author":"S Zhu","year":"2011","unstructured":"Zhu S, Zhang Y, Bai G, Li H . Necrostatin-1 ameliorates symptoms in R6\/2 transgenic mouse model of Huntington's disease. Cell Death Dis 2011; 2: e115.","journal-title":"Cell Death Dis"},{"key":"BFcddis201616_CR24","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.neuron.2014.01.011","volume":"81","author":"DB Re","year":"2014","unstructured":"Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 2014; 81: 1001\u20131008.","journal-title":"Neuron"},{"key":"BFcddis201616_CR25","doi-asserted-by":"publisher","first-page":"e48561","DOI":"10.1371\/journal.pone.0048561","volume":"7","author":"ZT Wehrmann","year":"2012","unstructured":"Wehrmann ZT, Hulett TW, Huegel KL, Vaughan KT, Wiest O, Helquist P et al. Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts. PLoS One 2012; 7: e48561.","journal-title":"PLoS One"},{"key":"BFcddis201616_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112\u2013119.","journal-title":"Nat Chem Biol"},{"key":"BFcddis201616_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","volume":"153B","author":"NM Yanjanin","year":"2010","unstructured":"Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK et al. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 132\u2013140.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFcddis201616_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00227765","volume":"85","author":"Y Higashi","year":"1993","unstructured":"Higashi Y, Murayama S, Pentchev PG, Suzuki K . Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol 1993; 85: 175\u2013184.","journal-title":"Acta Neuropathol"},{"key":"BFcddis201616_CR29","doi-asserted-by":"publisher","first-page":"26167","DOI":"10.1074\/jbc.M311591200","volume":"279","author":"D te Vruchte","year":"2004","unstructured":"te Vruchte D, Lloyd-Evans E, Veldman RJ, Neville DC, Dwek RA, Platt FM et al. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J Biol Chem 2004; 279: 26167\u201326175.","journal-title":"J Biol Chem"},{"key":"BFcddis201616_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10545-013-9610-6","volume":"37","author":"SM Cologna","year":"2014","unstructured":"Cologna SM, Cluzeau CV, Yanjanin NM, Blank PS, Dail MK, Siebel S et al. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1. J Inherit Metab Dis 2014; 37: 83\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"BFcddis201616_CR31","doi-asserted-by":"publisher","first-page":"16278","DOI":"10.1074\/jbc.M114.559914","volume":"289","author":"BE Kennedy","year":"2014","unstructured":"Kennedy BE, Madreiter CT, Vishnu N, Malli R, Graier WF, Karten B . Adaptations of energy metabolism associated with increased levels of mitochondrial cholesterol in Niemann-Pick type C1-deficient cells. J Biol Chem 2014; 289: 16278\u201316289.","journal-title":"J Biol Chem"},{"key":"BFcddis201616_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.expneurol.2004.03.002","volume":"187","author":"S Ohara","year":"2004","unstructured":"Ohara S, Ukita Y, Ninomiya H, Ohno K . Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann-Pick disease type C. Exp Neurol 2004; 187: 289\u2013298.","journal-title":"Exp Neurol"},{"key":"BFcddis201616_CR33","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1093\/hmg\/ddt206","volume":"22","author":"R Fu","year":"2013","unstructured":"Fu R, Wassif CA, Yanjanin NM, Watkins-Chow DE, Baxter LL, Incao A et al. Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1. Hum Mol Genet 2013; 22: 3508\u20133523.","journal-title":"Hum Mol Genet"},{"key":"BFcddis201616_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbd.2014.03.001","volume":"67","author":"IM Williams","year":"2014","unstructured":"Williams IM, Wallom KL, Smith DA, Al Eisa N, Smith C, Platt FM . Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol Dis 2014; 67: 9\u201317.","journal-title":"Neurobiol Dis"},{"key":"BFcddis201616_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.07-0101","volume":"21","author":"KB Peake","year":"2007","unstructured":"Peake KB, Hayashi H, Campenot R, Vance D, Vance J . Inflammation in the Niemann-Pick type-C brain. FASEB J 2007; 21: 1.","journal-title":"FASEB J"},{"key":"BFcddis201616_CR36","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","volume":"106","author":"B Liu","year":"2009","unstructured":"Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM . Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse. Proc Natl Acad Sci 2009; 106: 2377\u20132382.","journal-title":"Proc Natl Acad Sci"},{"key":"BFcddis201616_CR37","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","volume":"11","author":"M Zervas","year":"2001","unstructured":"Zervas M, Somers KL, Thrall MA, Walkley SU . Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr Biol 2001; 11: 1283\u20131287.","journal-title":"Curr Biol"},{"key":"BFcddis201616_CR38","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","volume":"106","author":"B Liu","year":"2009","unstructured":"Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM . Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-\/- mouse. Proc Natl Acad Sci USA 2009; 106: 2377\u20132382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis201616_CR39","doi-asserted-by":"publisher","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","volume":"4","author":"CD Davidson","year":"2009","unstructured":"Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K et al. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 2009; 4: e6951.","journal-title":"PLoS One"},{"key":"BFcddis201616_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/cdd.2012.133","volume":"20","author":"A Degterev","year":"2013","unstructured":"Degterev A, Maki JL, Yuan J . Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 2013; 20: 366.","journal-title":"Cell Death Differ"},{"key":"BFcddis201616_CR41","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1016\/j.bmcl.2008.08.058","volume":"18","author":"W Zheng","year":"2008","unstructured":"Zheng W, Degterev A, Hsu E, Yuan J, Yuan C . Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett 2008; 18: 4932\u20134935.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFcddis201616_CR42","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1016\/j.bmcl.2013.06.073","volume":"23","author":"Z Wu","year":"2013","unstructured":"Wu Z, Li Y, Cai Y, Yuan J, Yuan C . A novel necroptosis inhibitor-necrostatin-21 and its SAR study. Bioorg Med Chem Lett 2013; 23: 4903\u20134906.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFcddis201616_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.bmcl.2006.11.056","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang K, Li J, Degterev A, Hsu E, Yuan J, Yuan C . Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5. Bioorg Med Chem Lett 2007; 17: 1455\u20131465.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFcddis201616_CR44","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012; 3: e437.","journal-title":"Cell Death Dis"},{"key":"BFcddis201616_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-065X.2012.01149.x","volume":"249","author":"TL McGaha","year":"2012","unstructured":"McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast GC et al. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol Rev 2012; 249: 135\u2013157.","journal-title":"Immunol Rev"},{"key":"BFcddis201616_CR46","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1523\/JNEUROSCI.5282-06.2007","volume":"27","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, Sugimoto Y, Ohsaki Y, Ueno M, Kato S, Kitamura Y et al. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann\u2013Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain. J Neurosci 2007; 27: 1879\u20131891.","journal-title":"J Neurosci"},{"key":"BFcddis201616_CR47","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/jcbfm.2008.44","volume":"28","author":"Z You","year":"2008","unstructured":"You Z, Savitz SI, Yang J, Degterev A, Yuan J, Cuny GD et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008; 28: 1564\u20131573.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFcddis201616_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainres.2010.07.080","volume":"1355","author":"X Xu","year":"2010","unstructured":"Xu X, Chua KW, Chua CC, Liu CF, Hamdy RC, Chua BH . Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia\/reperfusion injury. Brain Res 2010; 1355: 189\u2013194.","journal-title":"Brain Res"},{"key":"BFcddis201616_CR49","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1177\/1087057114537378","volume":"19","author":"D Yu","year":"2014","unstructured":"Yu D, Swaroop M, Wang M, Baxa U, Yang R, Yan Y et al. Niemann-Pick disease type C: induced pluripotent stem cell-derived neuronal cells for modeling neural disease and evaluating drug efficacy. J Biomol Screen 2014; 19: 1164\u20131173.","journal-title":"J Biomol Screen"},{"key":"BFcddis201616_CR50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1126\/science.277.5323.232","volume":"277","author":"SK Loftus","year":"1997","unstructured":"Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A et al. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 1997; 277: 232\u2013235.","journal-title":"Science"},{"key":"BFcddis201616_CR51","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1093\/hmg\/dds193","volume":"21","author":"CV Cluzeau","year":"2012","unstructured":"Cluzeau CV, Watkins-Chow DE, Fu R, Borate B, Yanjanin N, Dail MK et al. Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. Hum Mol Genet 2012; 21: 3632\u20133646.","journal-title":"Hum Mol Genet"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis201616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201616","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T02:17:27Z","timestamp":1718417847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,17]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["BFcddis201616"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.16","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,17]]},"assertion":[{"value":"11 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}